Warts
Conditions
Brief summary
To assess the clinical efficacy and safety of topical imiquimod 5% cream combined with cryotherapy versus either of theme alone for the treatment of common warts by clinical and dermoscopic assessments.
Detailed description
Topical Imiquimod 5% cream Combined with Cryotherapy Versus either of them alone in Treatment of Common Warts: A prospective Randomized Comparative Trial
Interventions
None listed
Sponsors
Assiut University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* Patients with common warts diagnosed clinically and by dermoscopy. * Patients older than 18years old.
Exclusion criteria
* Pregnancy and lactation. * Immunosuppression or being under any kind of treatment causing * absolute or relative immunosuppression. * Patients with chronic systemic diseases. * All cases of bleeding tendency or using anticoagulants. * Concurrent use of systemic or topical treatments of warts in the last 4 weeks.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Complete clearance rate of common warts. | 12 weeks | Assessment of complete warts clearance rate at 12weeks to evaluate the efficacy of combination therapy ( imiquimod5%cream+cryotherapy ) compared to topical imiquimod5%cream alone or cryotherapy alone in patients with common wart. |
Contacts
Primary ContactEman Fathy Ahmed Lecturer of Dermatology, Venereology and Andrology Faculty of
Outcome results
None listed